SAB Biotherapeutics, Inc. (SABS) market cap

Market cap today
$265.76M

SAB Biotherapeutics, Inc. (SABS) has a market cap of $265.76M. At the end of fiscal 2025 (December 31, 2025) its market cap was $229.41M. That is 552.9% higher than the $35.14M of fiscal 2024. Today's figure is 15.8% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 09:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$265.76M
Market cap, fiscal 2025
$229.41M
Change on fiscal 2024
+552.9%
Highest on record
$229.41Mfiscal 2025
Lowest on record
$25.68Mfiscal 2022
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

SAB Biotherapeutics, Inc. market cap, in more detail

Across the 5 fiscal year-ends on record (2021–2025), the highest was $229.41M in fiscal 2025 and the lowest $25.68M in fiscal 2022.

History · 5 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

SAB Biotherapeutics, Inc. market cap, year by year

SAB Biotherapeutics, Inc. (SABS) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$265.76M—$2.95—
2025$229.41M 552.9% up$3.7461.34M
2024$35.14M 7.5% down$3.799.26M
2023$37.99M 47.9% up$6.885.52M
2022$25.68M 88.0% down$5.904.35M
2021$213.52M—$78.102.73M
2020———2.70M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on SABS

SAB Biotherapeutics, Inc., figure by figure

SAB Biotherapeutics, Inc. (SABS) overview: price, valuation and scorecard

SAB Biotherapeutics, Inc. market cap: questions and answers

What is SAB Biotherapeutics, Inc.'s market cap?

SAB Biotherapeutics, Inc. (SABS) has a market cap of $265.76M. At the end of fiscal 2025 (December 31, 2025) its market cap was $229.41M. That is 552.9% higher than the $35.14M of fiscal 2024.

What are the highest and lowest market cap figures on record for SAB Biotherapeutics, Inc.?

Across the 5 fiscal year-ends on record (2021–2025), the highest was $229.41M in fiscal 2025 and the lowest $25.68M in fiscal 2022.

How is SAB Biotherapeutics, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For SAB Biotherapeutics, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “SAB Biotherapeutics, Inc. (SABS) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/SABS/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.